MIRA INFORM REPORT

 

 

Report Date :

04.09.2014

 

IDENTIFICATION DETAILS

 

Name :

HIMEDIA LABORATORIES PRIVATE LIMITED

 

 

Registered Office :

23, Vadhani Industrial Estate, L.B.S. Marg, Ghatkopar (West), Mumbai - 400 086, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

08.09.1982

 

 

Com. Reg. No.:

11-028194

 

 

Capital Investment / Paid-up Capital :

Rs.18.225 Millions

 

 

CIN No.:

[Company Identification No.]

U85195MH1982PTC028194

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Dehydrated Culture Media, Vegetable Peptones and Microbiological Diagnostic.

 

 

No. of Employees :

650 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (54)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 2900000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having good track record.

 

Financial position of the company is sound.

 

Trade relations are fair. Business is active. Payment terms are reported to be regular and as per commitment.

 

The company can be considered normal for normal business dealings at usual trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

As per the latest IMF study, the total weigh of emerging markets in the GDP of the world on a purchasing power parity basis has seen a sizeable shift. It highlights how as against 51 % in 2005, the emerging economies now account for close to 56 % of the global purchasing power GDP as per the latest survey. And with the emerging economies growing at a faster rate than their developed counterparts, there are every possibility that the their share goes up further in the coming years.  China may surpass the US over the next few years.

 

Politics and economics are very intricately connected. They tend to influence each other in ways that could be very complex and far-reaching. The prospects of the India’s economy have been seriously compromised due to political corruption. High inflation, poor standard of living are to a great extent a result of rampant corruption in the country. China on the other hand, seems to be facing diametrically opposite challenge. American hedge fund manager Jim Chanos has been keenly following the political and economic development in the dragon economy and has figured out something that is quite worrying. He is of the view that the Chinese economy could be heading toward trouble on account of new Chinese President Xi Jingping’s very aggressive anti-corruption drive. Chanos believes tat many things such as apartment sales, luxury products, etc. were largely bought with dirty money. And it is now beginning to impact consumption. This may indeed be bad news for an economy that is struggling to transition from an investment-driven export-oriented economy to a domestic consumption-driven economy.

 

A study published by Firstpost has revealed that asset classes like real estate and equities were the biggest beneficiaries of the liberalization policies.  A firm called Ciane Analytics studied returns from assets including equities, gold, fixed deposits, G-Secs and real estate since 1991. Real estate outperformed every other asset classes during the 23-year period with an annualized return of 20 % ! Equities came in second with annualized return of 15.5 % ! However, while these returns may seem mouthwatering, the fact is that the return from equities adjusted for inflation came down to just 7.1 %.

 

Some brief news are as under

. R-Power to buy Jaypee’s hydro assets

. Investors await justice in NSEL case

. India seeks MFN status from Pakistan ahead of meeting

. Ukrain’s clashes with rebels hinder MH17 crash investigation

. India exploring merger of state-owned hydro PSUs

..Higher costs weigh down profit growth to slowest in 9 quarters

..Wal-Mart to expand wholesale business in India

. GMR group moves to strengthen balance sheet

. Central Bank to sell 4 % stake to Life Insurance Corporation

. Tata Chemicals plans to raise up to Rs 10000 mn.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term rating: A-

Rating Explanation

Adequate degree if safety. It carry low credit risk.

Date

13.03.2014

 

Rating Agency Name

CRISIL

Rating

Short term rating: A2+

Rating Explanation

Strong degree of safety. It carry low credit risk.

Date

13.03.2014

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION DECLINED BY

 

Name :

Mr. Basant

Designation :

Finance Manager

Contact No.:

91-22-25000970

Date :

01.09.2014

 

 

LOCATIONS

 

Registered/ Head Office :

23, Vadhani Industrial Estate, L.B.S. Marg, Ghatkopar (West), Mumbai - 400 086, Maharashtra, India

Tel. No.:

91-22-25001607/ 61169797

Fax No.:

91-22-25005764 / 25002468 / 25002286

E-Mail :

accounts@himedialabs.com

info@himedialabs.com

Website :

www.himedialabs.com

www.himedia.com

Area :

1000 sq. ft.

Location :

Owned

 

 

Corporate Office : 

A 516, Swastik Disha Business Park, via Vadhani Industrial Estate, L.B.S. Marg, Mumbai-400086, Maharashtra, India

Tel. No.:

91-22-61471919 / 25003747 / 25000970 / 25000278

Fax No.:

91-22-40951920 / 25005764 / 25002468

 

 

 

 

Factory 1 :

Plot No. W-239(B), MIDC Industrial Area, Phase II, Dombivali (East), Thane, Maharashtra, India

 

 

Factory 2 :

Plot No. B-6 in Dindori Industrial Area, Village Palkhed, Taluka Dindori, District Nasik, Maharashtra, India

 

 

Warehouse:

Located at

 

Bhiwandi

 

 

DIRECTORS

 

As on 28.09.2013

 

Name :

Dr. Gangandhar Warke

Designation :

Managing Director

Address :

1 33 Prim Rose, Tata Glendale, Pokharan Road No. 2, Thane – 400610, Maharashtra, India

Date of Birth/Age :

16.09.1941

Qualification:

M.Sc.,

Date of Appointment :

08.09.1992

PAN No.:

AAAPW0772D

DIN No.:

00131921

 

 

Name :

Mr. Vishnu Warke

Designation :

Whole Time Director

Address :

C-2/ 1002, 10th Floor, Lok Everest, J. D. Road, Mulund, Mumbai – 400 080, Maharashtra, India

Date of Birth/Age :

03.07.1945

Qualification:

B.Sc.,

Date of Appointment :

08.09.1992

PAN No.:

AAAPW2012N

DIN No.:

00143047

 

 

Name :

Mr. Vishal Gangadhar Warke

Designation :

Whole Time Director

Address :

131, 13th Floor, Prime Rose Gladys A Lverex Road-Village Majiwade, Thane – 400 607, Maharashtra, India

Date of Birth/Age :

29.04.1973

Date of Appointment :

01.08.2004

PAN No.:

AAIPW9404G

DIN No.:

00143167

 

 

Name :

Mr. Anil Tryambak Warke

Designation :

Whole Time Director

Address :

Mathura Anandghan Co-Operative Society, Sant Namdeo Path, Dombivali (East), Thane – 421 201, Maharashtra, India

Date of Birth/Age :

30.07.1960

Date of Appointment :

01.05.1998

PAN No.:

AAAPW2003R

DIN No.:

00143275

 

 

Name :

Mr. Rahul Gangadhar Warke

Designation :

Whole Time Director

Address :

134, 13th Floor, Prime Rose Gladys Al Wares Marg, Pokhran Road No.2, Thane – 400 602, Maharashtra, India

Date of Birth/Age :

19.09.1974

Qualification:

M.Sc.,

Date of Appointment :

01.04.2006

PAN No.:

AAIPW9403B

DIN No.:

00143397

 

 

Name :

Mrs. Priti Vishal Warke

Designation :

Whole Time Director

Address :

1 33 Prim Rose, Tata Glendale, Pokharan Road No. 2, Thane – 400610, Maharashtra, India

Date of Birth/Age :

11.12.1976

Date of Appointment :

01.08.2005

PAN No.:

AAQPW2037H

DIN No.:

00809839

 

 

Name :

Mr. Rajas Vishnu Warke

Designation :

Director

Address :

C-2/ 1002, 10th Floor, Lok Everest, J. D. Road, Mulund, Mumbai – 400 080, Maharashtra, India

Date of Birth/Age :

06.02.1978

Date of Appointment :

16.06.2008

PAN No.:

AAIPW9405H

DIN No.:

02247355

 

 

Name :

Mr. Pravin Tryambak Warke

Designation :

Whole Time Director

Address :

Madhura Building, Anandgaon Sant Namdeo Path, Dombivli, Thane – 421 201, Maharashtra, India

Date of Birth/Age :

15.07.1965

Date of Appointment :

01.08.2005

PAN No.:

AAAPW2137Q

DIN No.:

01672973

 

 

Name :

Mr. Dinkar G Charudhari

Designation :

Director

Address :

4, Sai Nagar Apartments, Next to Uttam Society, Chembur, Mumbai – 400071, Maharashtra, India

Date of Birth/Age :

01.04.1939

Date of Appointment :

03.01.2002

 

 

Name :

Mr. Laxman S Bhole

Designation :

Director

Address :

K-22, Ganaji Raj Cooperative Housing Society, Mitha Nagar Road, Mulund East, Mumbai – 400081, Maharashtra, India

Date of Birth/Age :

01.06.1942

Date of Appointment :

03.01.2002

 

KEY EXECUTIVES

 

Name :

Mr. Basant

Designation :

Finance Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 28.09.2013

 

Names of Shareholders

 

No. of Shares

Gangadhar M. Warke

60201

Vishnu M. Warke

60201

Tryambak M. Warke

675

Jyoti A. Warke

Anil T. Warke

1350

Pravin. T. Warke

T. M. Warke

180

Pravin T. Warke

Sangeeta. P. Warke

19710

Ramesh T. Warke

T. M Warke

90

R. Ramesh T. Warke

S. R. Warke

19710

Anil T. Warke

T. M. Warke

3960

Anil T. Warke

J. A. Warke

14580

Rajas V. Warke

270

Saroj G. Warke

135

Swati V. Warke

135

Vishal G. Warke

135

Rahul G. Warke

135

Gangadhar M. Warke (HUF)

135

Vishnu M. Warke (HUF)

135

Promino Health Product Private Limited, India

135

P. T. Warke (HUF), India

90

Sulochana Mahajan

90

R. T. Warke (HUF), India

90

A. T. Warke (HUF), India

90

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 28.09.2013

 

Category

Percentage

Directors or relatives of Directors

100

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Dehydrated Culture Media, Vegetable Peptones and Microbiological Diagnostic.

 

 

Products :

 

ITC Code

Description of product

13019019

Chemicals

13023100

Chemicals

19019010

Chemicals

21021010

Media Base

28152000

Chemicals

29181190

Chemicals

30012020

General Media

30059090

Plastic wares

32041990

Chemicals

35019000

Media Base

35040010

Media Base

35071019

Chemicals

38210000

Sensitivity Disc

38220090

Chemicals

39201019

Plastic wares

39233090

Plastic wares

39269099

Plastic wares

73269000

Laboratory Aids

84191920

Laboratory Aids

90172010

Laboratory Aids

90189019

Plastic wares

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

 

PRODUCTION STATUS (AS ON: 31.03.2011)

 

Particulars

Unit

Installed Capacity

 

 

 

Biological Dehydrated Culture Media, Media bases

MT

3950 (Approximately)

 

 

GENERAL INFORMATION

 

No. of Employees :

650 (Approximately)

 

 

Bankers :

State Bank of India, N.G.N. Vaidya Marg, Bank Street, Fort,, Mumbai - 400001,

Maharashtra, India

 

 

Facilities :

Secured Loan

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

Long-term Borrowings

 

 

Working capital loans from banks

0.394

1.100

 

 

 

Short-term borrowings

 

 

Working capital loans from banks

356.609

328.302

 

 

 

Total

357.003

329.402

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

A.B. Jog and Company

Chartered Accountants

Address :

604-B, Manisha Apartments, Church Road, Marol, Andheri (East), Mumbai - 400 059, Maharashtra, India

Tel. No.:

91-22-28209245

Fax No.:

91-22-24313042

PAN N Income-tax PAN of auditor or auditor's firm :

AAFPJ0523Q

 

 

Parties where control exists (subsidiaries) :

·         Himedia Laboratories, LLC, U.S.A

 

 

Enterprises Having Common Key Management Personnel and Their Relatives:

·         Warkem Biotech Private Limited, India [U24200MH2005PTC150416]

·         Pure Nutriplant Chemicals Private Limited

·         Promino Health Products Private Limited

·         Agencia LaDiagnos

·         X-pert Computer Consultants

·         Biopharmaceutical Enterprises

·         H.P.Works

·         Biotech Consultants

·         Promino Products

·         Warke Family trust

 

 

CAPITAL STRUCTURE

 

As on 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

500000

Equity Shares

Rs.100/- each

Rs. 50.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

182250

Equity Shares

Rs.100/- each

Rs. 18.225 Millions

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2013

31.03.2012

31.03.2011

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

18.225

18.225

18.225

(b) Reserves & Surplus

700.108

560.059

494.432

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

718.333

578.284

512.657

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

273.712

258.632

156.342

(b) Deferred tax liabilities (Net)

13.288

12.678

13.741

(c) Other long term liabilities

148.478

137.470

123.445

(d) long-term provisions

4.564

2.140

1.489

Total Non-current Liabilities (3)

440.042

410.920

295.017

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

356.809

329.287

384.245

(b) Trade payables

189.904

159.003

144.234

(c) Other current liabilities

66.274

72.776

70.840

(d) Short-term provisions

75.035

43.627

64.303

Total Current Liabilities (4)

688.022

604.693

663.622

 

 

 

 

TOTAL

1846.397

1593.897

1471.296

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

454.859

437.045

386.569

(ii) Intangible Assets

2.974

1.357

0.845

(iii) Capital work-in-progress

0.609

28.862

44.461

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.452

0.013

0.003

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

43.768

25.871

26.765

(e) Other Non-current assets

0.574

1.963

0.065

Total Non-Current Assets

503.236

495.111

458.708

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

640.424

520.973

469.513

(c) Trade receivables

463.584

330.261

290.433

(d) Cash and cash equivalents

162.059

174.643

177.337

(e) Short-term loans and advances

70.297

57.690

64.151

(f) Other current assets

6.797

15.219

11.154

Total Current Assets

1343.161

1098.786

1012.588

 

 

 

 

TOTAL

1846.397

1593.897

1471.296

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Sales

2129.258

1642.454

1456.996

 

 

Other Income

NA

NA

NA

 

 

TOTAL                                    

NA

NA

NA

 

 

 

 

 

Less

EXPENSES

 

 

Office Expenses

 

 

 

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

NA

NA

NA

 

 

 

 

 

 

PROFIT BEFORE TAX

274.257

160.557

228.797

 

 

 

 

 

Less

TAX                                                                 

91.845

52.567

73.525

 

 

 

 

 

 

PROFIT AFTER TAX

182.412

107.990

155.272

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

18.542

27.083

16.596

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

General Reserve

131.604

74.168

108.335

 

 

Dividend (Interim and Final)

42.363

42.363

36.450

 

BALANCE CARRIED TO THE B/S

26.987

18.542

27.083

 

 

 

 

 

 

FOB VALUE OF EXPORT

667.438

483.254

395.527

 

 

 

 

 

 

CIF VALUE OF IMPORT

406.730

236.576

253.465

 

 

 

 

 

 

Earnings Per Share (Rs.)

1001.00

593.00

NA

 

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

Net Profit Margin

(PBT/Sales)

(%)

12.88

9.78

15.70

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

14.86

10.26

16.04

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.38

0.28

0.45

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.88

1.02

1.05

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.95

1.82

1.53

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

18.225

18.225

18.225

Reserves & Surplus

494.432

560.059

700.108

Net worth

512.657

578.284

718.333

 

 

 

 

long-term borrowings

156.342

258.632

273.712

Short term borrowings

384.245

329.287

356.809

Total borrowings

540.587

587.919

630.521

Debt/Equity ratio

1.054

1.017

0.878

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

1456.996

1642.454

2129.258

 

 

12.729

29.639

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

1456.996

1642.454

2129.258

Profit

155.272

107.990

182.412

 

10.66%

6.57%

8.57%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

OPERATIONS:

 

The company registered an increase in domestic turnover by 27% and in export turnover by 35% over that of the previous year. This is the result of the marketing efforts of the directors.

 

As expected and mentioned in their report last year, they had targeted a turnover of Rs.1950.000 Millions. The management was successful in surpassing the target to reach 2130.000 Millions inspite of recessionary conditions throughout the world. The sales promotion efforts are continuously going on and enabling the company to exploit the full potential of markets in India and abroad. This is evident from the increased turnover for the year in spite of competitive conditions in the country and in the global economy. A better utilization of resources has enabled the Company to increase the profit after tax for the year. The healthcare scenario of the country has been changing for the better due to increased awareness from the government and among the general public. An encouraging quantum of enquiries is being received. The turnover for the first five months of the current year, which is normally a lean period, has amounted to Rs.788.900 Millions. The directors are optimistically confident of not only achieving a target of Rs.2700.000 Millions set for the current year, but exceeding the same.

 

During the year under review, the company has taken strides in the introduction of new products. These products are the results of the Research and Development efforts of the company in the field of vegetable based peptone, Plant tissue culture cells, and monoclonal and polyclonal antibodies, Animal cell culture media and Molecular Biological kits. These products are finding acceptability in domestic and foreign markets, both existing and new. Kits to test rapid growth of bacteria are being well accepted. Various in-vitro diagnostic reagents continue to find a ready global market. The Company introduced during the year complete detection of Sickle cell kit in Hematology range, harmonized media for Pharmaceutical industries and developed economical version of water testing kit. The company introduced first time in the world the rapid and simple diagnostic kits for pharmaceutical, clinical, food, water and milk testing and isplanning to take the patent for the same.

 

The company has already successfully started marketing Hiveg products in USA. Also regular medias are also created besides veg products. The Company is also targeting Hiveg products in fermentation industries where animal based products will be replaced with Hiveg products. A-comprehensive range of stem cells, primary cells and their media were launched during this year.

 

Stem cell, which is a new field, was launched in the last year and it is significantly contributing to increase in turnover.

 

Due to these circumstances the directors are hopeful of achieving the projected turnover in this financial year also.

 

Central Logistic Warehouse: - To facilitate more prompt service to customers, the directors have established duty paid warehouse at Bhiwandi for Domestic markets.

 

 

UNSECURED LOAN

 

PARTICULARS

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

Long-term Borrowings

 

 

Deferred sales tax loan

119.912

119.927

Loans and advances from directors

118.647

104.446

Loans and advances from others

34.759

33.159

 

 

 

Short-term borrowings

 

 

Loans and advances from related parties

0.200

0.985

 

 

 

Total

273.518

258.517

 

 

INDEX OF CHARGES

 

S. No.

Charge id

Date of charge creation/modification

Charge amount secured

Charge holder

Address

Service request number (srn)

1

90243478

04/02/2004 *

141,800,000.00

STATE BANK OF INDIA

L B S ROAD, MUMBAI, MAHARASHTRA, INDIA

-

2

90186763

11/05/2013 *

570,000,000.00

STATE BANK OF INDIA

MUMBAI COMMERCIAL BRANCH, N.G.N. VAIDYA MARG, HORNIMAN CIRCLE, BANK STREET, FORT, MUMBAI, MAHARASHT
RA - 400001, INDIA

B75569236

3

90184117

21/07/1999

53,000,000.00

STATE BANK OF INDIA

SSI BUSINESS BRANCH; GHATKOPAR (WEST) BRANCH, L.B .S MARG; GHATKOPAR, MUMBAI,MAHARASHTRA - 400086, INDIA

-

4

90186618

11/11/1998

66,000,000.00

STATE BANK OF INDIA

ASHOK MILLS COMPOUND; L.B.S ROAD, GHATKOPAR WEST, MUMBAI, MAHARASHTRA - 400086, INDIA

-

5

90242142

10/01/2014 *

570,000,000.00

STATE BANK OF INDIA

N.G.N. VAIDYA MARG,, BANK STREET, FORT,, MUMBAI, MAHARASHTRA - 400001, INDIA

B98305758

6

90184076

30/07/2004 *

53,000,000.00

STATE BANK OF INDIA

ASHOK MILLS COMPOUND; L.B.S ROAD, GHATKOPAR WEST, MUMBAI, MAHARASHTRA - 400086, INDIA

-

7

90186467

17/07/2000 *

53,000,000.00

STATE BANK OF INDIA

ASHOK MILLS COMPOUND, L.B.S ROAD; GHATKOPAR WEST, MUMBAI, MAHARASHTRA - 400086, INDIA

-

8

90186415

17/01/1997

53,000,000.00

STATE BANK OF INDIA

SPECIALISED SMALL INDUSTRY ESTATE BRANCH, MUMBAI,
MAHARASHTRA - 400086, INDIA

-

9

90184038

11/03/1996

30,500,000.00

UNION BANK OF INDIA

DHANLAXMI INDUSTRIAL ESTATE, MAJIWADA, THANE, MAH ARASHTRA - 400601, INDIA

-

10

90186177

04/03/1995

3,500,000.00

UNION BANK OF INDIA

DHANLAXMI INDL. SERVICES AMRUTNAGAR, 1ST FLOOR; MAJIWADA, THANE, MAHARASHTRA - 400601, INDIA

-

 

* Date of charge modification

 

 

CONTINGENT LIABILITIES:

(Rs. in millions)

PARTICULARS

31.03.2013

Counter Guarantees issued in favour of Scheduled Banks in respect of Guarantees and Letters of credit opened and outstanding at the end of the year:

 

Bank Guarantee (Domestic -Net )

1.676

Bank Guarantee (International)

0.969

Letters of Credit in favour of foreign suppliers

6.370

( Margin held by bank against above (a+b+c) in form of Term Deposit Receipts pledged )

5.945

Credit facilities granted to an associate concern

38.953

 

a) Sales Tax ( VAT since 01.04.2005) Assessments are completed up to financial year ended 31.03.09 in respect of units in backward area and up to 31-03-2007 in respect of other operation and there are no demands outstanding. For assessment under MVAT act 2005, VAT audit report is treated as assessment and there are no VAT dues. However a demand of Rs. 0.787 Million against penalty for late filling of VAT audit report for the year ended 31.03.2007 has been raised against company, against which appeal has been preferred and decision is awaited. Final Liability for unassessed years remains unascertained. Set off of tax on purchase up to financial year ended 31-03-2005 had been accounted on the basis of returns filed and is adjusted on assessment as per order of assessment.

 

b) For Current Year under review there is a contingent liability of Rs.19.022 Millions (P.Y.Rs.14.066 Millions) on account of differential sales and value added tax due to non-receipts of prescribed declaration forms in anticipation of which lower rate of tax has been charged in the invoices. The management is however making all efforts for obtaining such forms from customers.

 

iii) Interest accrued on term loans from a financial institution falling due within next 12 month from the date of balance sheet is Rs. 0.104 Millions.

 

iv) The Income tax assessments have been completed upto the accounting year ended 31.03.2010 i.e A.Y. 2010-11. The demand raised by the Income tax authorities for A.Y 2009-10 has been disputed by the company and the company has filed appeal against the said order with I.T.A.T Mumbai.

 

The demand raised by the Income tax authorities for A.Y 2010-11 has been disputed by the company and the company has filed appeal against the said order with CIT (Appeals)- 21,Mumbai. The interest on income tax refunds or assessment dues is accounted in the year of receipt for refund and finality of appellate remedies and its effect given to in case of demand. The final liability in respect of unassessed years from F.Y. ended 31-3-2010 onwards remains indeterminate. The same has been disclosed under Contingent Liabilities with amount indeterminate.

 

 

FIXED ASSETS

 

Tangible assets

 

·         Land

·         Buildings

·         Plant and equipment

·         Furniture and fixtures

·         Vehicles

·         Office equipment

·         Computer equipments

·         Computer software

·         Know-how

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.65

UK Pound

1

Rs.99.73

Euro

1

Rs.79.54

 

 

INFORMATION DETAILS

 

Information Gathered by :

DIP

 

 

Analysis Done by :

DIV

 

 

Report Prepared by :

NKT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

54

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.